The Patent Finder

Precision for Medicine GmbH

22 patents currently held · Updated Nov 20, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Epiontis GmbH (to 2021)

2
Ending by 2030
Feb 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Dec 6 to 20, 2026 · next Dec 6
  • 1 fee due Feb 15, 2027
    The maintenance fee for Epigenetic Method for the Identification of Follicular T-Helper-(TFH-) Cells (US 11,725,243) comes due Feb 15, 2027. Unpaid by Aug 16, 2027, it lapses early.
  • 2 fees due Mar 12 to 19, 2027 · next Mar 12
  • 1 fee due Apr 17, 2027
    The maintenance fee for MVD as epigenetic marker for the identification of immune cells, in particular CD56+ NK cells (US 11,788,141) comes due Apr 17, 2027. Unpaid by Oct 18, 2027, it lapses early.
  • 1 fee due Sep 17, 2027
    The maintenance fee for Detection of immune cells, in particular T cells through DNA-methylation analysis of the genes CCR6 and BLR1 (US 10,590,475) comes due Sep 17, 2027. Unpaid by Mar 17, 2028, it lapses early.
  • 1 fee due Nov 7, 2027
    The maintenance fee for ERGIC1 as Epigenetic Marker for the Identification of Immune Cells, in Particular Monocytic Myeloid-Derived Suppressor Cells (mMDSCs) (US 11,976,327) comes due Nov 7, 2027. Unpaid by May 8, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 22, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,876,163Detection and quality control of regulatory T cells through DNA-methylation analysis of the Foxp3 gene
In force
 · High confidence
In forceHigh confidence
US 12,286,675Epigenetic markers for the identification of blood sub-cells of type 1
In force
 · USPTO record
In forceUSPTO record
US 10,590,475Detection of immune cells, in particular T cells through DNA-methylation analysis of the genes CCR6 and BLR1
In force
 · USPTO record
In forceUSPTO record
US 10,273,545Epigenetic Method for the Identification of Subpopulations of CD8+ T Lymphocytes, in Particular CD8 Alpha and Beta T Lymphocytes
In force
 · High confidence
In forceHigh confidence
US 10,781,492Epigenetic method for the identification of subpopulations of CD8+ T lymphocytes, in particular CD8 alpha and beta T lymphocytes
In force
 · USPTO record
In forceUSPTO record
US 10,208,346Method for identifying the quantitative cellular composition in a biological sample
In force
 · USPTO record
In forceUSPTO record
US 10,894,984Method for identifying the quantitative cellular composition in a biological sample
In force
 · USPTO record
In forceUSPTO record
US 11,643,687LRP5 as Epigenetic Marker for the Identification of Immune Cells, in Particular B-Cells
In force
 · High confidence
In forceHigh confidence
US 11,761,041PARK2 as epigenetic marker for the identification of immune cells, in particular monocytes
In force
 · USPTO record
In forceUSPTO record
US 11,788,141MVD as epigenetic marker for the identification of immune cells, in particular CD56+ NK cells
In force
 · USPTO record
In forceUSPTO record
10 of 22 patents shown.
Pro members see all 22.
Pro members: see all 22 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited